HPLC-MS/MS-based quantification of human monoclonal antibodies targeting SARS-CoV-2 in the presence of endogenous SARS-CoV-2 antibodies in human serum.

MLA

Schäfer, Alexander, et al. “HPLC-MS/MS-Based Quantification of Human Monoclonal Antibodies Targeting SARS-CoV-2 in the Presence of Endogenous SARS-CoV-2 Antibodies in Human Serum.” Analytical and Bioanalytical Chemistry, vol. 416, no. 19, Aug. 2024, pp. 4383–96. EBSCOhost, https://doi.org/10.1007/s00216-024-05375-w.

APA

Schäfer, A., Sagelsdorff, P., Hock, B., Bhuyan, P., Moullan, N., & Siethoff, C. (2024). HPLC-MS/MS-based quantification of human monoclonal antibodies targeting SARS-CoV-2 in the presence of endogenous SARS-CoV-2 antibodies in human serum. Analytical and Bioanalytical Chemistry, 416(19), 4383–4396. https://doi.org/10.1007/s00216-024-05375-w

Chicago

Schäfer, Alexander, Peter Sagelsdorff, Björn Hock, Prakash Bhuyan, Norman Moullan, and Christoph Siethoff. 2024. “HPLC-MS/MS-Based Quantification of Human Monoclonal Antibodies Targeting SARS-CoV-2 in the Presence of Endogenous SARS-CoV-2 Antibodies in Human Serum.” Analytical and Bioanalytical Chemistry 416 (19): 4383–96. doi:10.1007/s00216-024-05375-w.